News
Hosted on MSN1mon
Maxim Group Upgrades Moleculin Biotech (MBRX)Fintel reports that on March 25, 2025, Maxim Group upgraded their outlook for ... Inc. is a clinical stage pharmaceutical company focused on the development of a broad portfolio of oncology ...
Maxim Group’s price objective would suggest a ... scPharmaceuticals Inc, a pharmaceutical company, engages in the development and commercialization of various pharmaceutical products.
Results that may be inaccessible to you are currently showing.
Hide inaccessible results